1. Glowska-Ciemny J, Pankiewicz J, Malewski Z, Von Kaisenberg C, Kocylowski R. Alpha-fetoprotein (AFP) - new aspects of a well-known marker in perinatology. Ginekol Pol. 2022;93(1):70-5. [
DOI:10.5603/GP.a2021.0226] [
PMID]
2. Masihi S, Ebrahimi-Lagha M, Barati M, Saadati N, Farhadi E. Evaluation of the Role of Maternal Serum Alpha-Phytoprotein (Ms-Afpi In The Management of Perinatal Care. Eur Chem Bull. 2023;12(4):11948-56.
3. Ling Y, Yu Y-H, Jin S, Hu C-X, Peng W, Zhang H-Y, et al. Study of concentration of amniotic fluid alpha-fetal protein in thalassemia fetus. Asian Pac J Trop Med. 2017;10(2):201-3. [
DOI:10.1016/j.apjtm.2017.01.001] [
PMID]
5. Naeem DSM, Al-Nakkash DUMAJ. The association of Maternal Alpha fetoprotien and BHCG with umbilical artery pattern in mid trimester. Int j Clin Obstet Gynaecol. 2021;5(3):80-4. [
DOI:10.33545/gynae.2021.v5.i3b.906]
6. Gurashi RA, Fadl-Elmula I. Maternal Serum Triple Screening Test and Pregnancy Outcome in Elderly Sudanese Pregnant Ladies in Khartoum State-Sudan. Am J Lab Med. 2017;2(6):172-8. [
DOI:10.11648/j.ajlm.20170206.19]
8. Abd Elraheim MM, Abd Elraheim IM, Mohamed MA, Mohamed AH. Alpha feto protein in obstetrics. Sohag Med J. 2020;24(2):187-91. [
DOI:10.21608/smj.2020.24854.1109]
9. Bartkute K, Balsyte D, Wisser J, Kurmanavicius J. Pregnancy outcomes regarding maternal serum AFP value in second trimester screening. J Perinat Med. 2017;45(7):817-20. [
DOI:10.1515/jpm-2016-0101] [
PMID]
10. Mir H, Sadiq S, Musharaf S. Maternal serum alpha-feto-protein as a predictor of the pregnancy outcome. Eur J Mol Clin Med. 2021;8(04):2021.
11. Başbuğ D, Başbuğ A, Gülerman C. Is unexplained elevated maternal serum alpha-fetoprotein still important predictor for adverse pregnancy outcome? Ginekol Pol. 2017;88(6):325-30. [
DOI:10.5603/GP.a2017.0061] [
PMID]
12. Dong N, Gu H, Liu D, Wei X, Ma W, Ma L, et al. Complement factors and alpha‐fetoprotein as biomarkers for noninvasive prenatal diagnosis of neural tube defects. Ann N Y Acad Sci. 2020;1478(1):75-91. [
DOI:10.1111/nyas.14443] [
PMID]
13. Corroenne R, Zhu K, Orman G, Huisman TAGM, Mehollin-Ray AR, Johnson E, et al. Maternal serum alpha-fetoprotein level and the relationship to ventriculomegaly in fetal neural tube defect: A retrospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2021;259:185-90. [
DOI:10.1016/j.ejogrb.2021.02.010] [
PMID]
14. Pradhan A, Mishra P, Tiwari S, Choure K, Gupta A. Prediction of Low Birth Weight by Quadruple Parameters in High-Risk Pregnancies. Int j Appl Basic Med Res. 2022;12(4):277-83. [
DOI:10.4103/ijabmr.ijabmr_155_22] [
PMID] [
PMCID]
15. Hu J-L, Zhang Y-J, Zhang J-M, Zhu S, Li D-M, Yin Y-F, et al. Pregnancy outcomes of women with elevated second-trimester maternal serum alpha-fetoprotein. Taiwan J Obstet Gynecol. 2020;59(1):73-8. [
DOI:10.1016/j.tjog.2019.11.011] [
PMID]
16. Alizadeh-Dibazari Z, Alizadeh-Ghodsi Z, Fathnezhad-Kazemi A. Association Between Serum Markers Used in the Routine Prenatal Screening with Pregnancy Outcomes: A Cohort Study. J Obstet Gynaecol India. 2022;72(Suppl 1):6-18. [
DOI:10.1007/s13224-021-01508-8] [
PMID] [
PMCID]
17. Alvarez-Nava F, Soto M, Lanes R, Pons H, Morales-Machin A, Bracho A. Elevated second-trimester maternal serum β-human chorionic gonadotropin and amniotic fluid alpha-fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome. J Obstet Gynaecol Res. 2015;41(12):1891-8. [
DOI:10.1111/jog.12813] [
PMID]
18. Goto E. Association of high maternal blood alpha-fetoprotein level with risk of delivering small for gestational age: a meta-analysis. Pediatr Res. 2020;89(7):1742-50. [
DOI:10.1038/s41390-020-01124-8] [
PMID]
19. Taghavipour M, Galini-Moghaddam T, Mousavi SJ. First and Second-Trimester Maternal Serum Analytes for the Prediction of Adverse Pregnancy Outcomes. J Obstet Gynecol Cancer Res. 2021;6(1):22-8. [
DOI:10.30699/jogcr.6.1.22]
20. Turkgeldi LS, Turkgeldi E, Kiyak H, YÜCel N. Abnormal First And Second Trimester Matenal Seum Marker Levels For Aneuploidy Screening And Adverse Pregnancy Outcomes. East J Med. 2021;26(3):418-25. [
DOI:10.5505/ejm.2021.77775]
21. Singh SS, Vini Gupta A. Association between second trimester maternal serum alpha fetoprotein in 14-22 weeks and adverse pregnancy outcome. Eur J Mol Clin Med. 2022;9(1):1035-9.
22. Karya U, Kumari S, Rani A, Singh S. Clinical significance of unexplained elevated maternal serum alpha feto-protein in second trimester of pregnancy. Int j Reprod Contracept Obstet Gynecol. 2018;7(6):2245. [
DOI:10.18203/2320-1770.ijrcog20182329]
23. Mir H, Sadiq S, Malik S. Association between second trimester maternal serum alphafetoprotein in 14-22 weeks and adverse pregnancy outcome. Eur J Mol Clin Med. 2022;9(1):225-31.
24. Yassaee F, Shekarriz-Foumani R, Sadeghi S. Amniocentesis following positive first trimester combined screening: A comparative study. Acta Med Iran. 2019;57(6). [
DOI:10.18502/acta.v57i6.1879]
25. Ciortea R, Malutan AM, Bucuri CE, Berceanu C, Rada MP, Ormindean CM, Mihu D. Amniocentesis-When It Is Clear That It Is Not Clear. J Clin Med. 2023;12(2):454. [
DOI:10.3390/jcm12020454] [
PMID] [
PMCID]
26. Sharony R, Dayan D, Kidron D, Manor M, Berkovitz A, Biron-Shental T, Maymon R. Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications? Arch Gynecol Obstet. 2016;293:767-70. [
DOI:10.1007/s00404-015-3905-9] [
PMID]
27. Yue C-Y, Zhang C-Y, Ying C-M. Serum markers in quadruple screening associated with adverse pregnancy outcomes: A case-control study in China. Clin Chim Acta. 2020;511:278-81. [
DOI:10.1016/j.cca.2020.10.029] [
PMID]
28. Celik OY, Obut M, Keles A, Calık MG, Dagdeviren G, Yucel A, Sahin D. Outcomes of pregnancies diagnosed with circumvallate placenta, and use of uterine artery pulsatility index and maternal serum alpha-fetoprotein for prediction of adverse outcomes. Eur J Obstet Gynecol Reprod Biol. 2021;262:57-61. [
DOI:10.1016/j.ejogrb.2021.05.008] [
PMID]
29. Dabiri Oskoei A, Jamshidasl M, Faghihzadeh S, Esmaeilzadeh A, F B. The relationship between amniotic fluid alpha-fetoprotein, alkaline phosphatase and ferritin in the second trimester of pregnancy and preterm birth. Iran J Obstet Gynecol Infertil. 2019;22(2):9-16.
30. Mahmooda E, Helaly L, Yousif T. Studying of some proteins levels and enzymes activities in the amniotic fluid for pregnant associated with premature birth. Libyan j Sci Technol. 2021;16(2):116-20. [
DOI:10.37376/ljst.v13i2.2319]
31. Yazdani S, Rouholahnejad R, Asnafi N, Sharbatdaran M, Zakershob M, Bouzari Z. Correlation of pregnancy outcome with quadruple screening test at second trimester. Med J Islam Repub Iran. 2015;29:281.
32. Izairi P, Velickova N. Association of adverse pregnancy outcome with the values of serum biomarkers of Quadruple test. Alban J Med Health Sci. 2021;57:1-12.
33. Erol SA, Altinboga O, Yakistiran B, Halici Ozturk F, Baser E, Caglar AT. Evaluation of Actual Maternal Serum Alpha-Fetoprotein (MSAFP) Levels in Placental Abruption and Associations with Adverse Outcomes. SN Compr Clin Med. 2021;3(2):611-7. [
DOI:10.1007/s42399-021-00794-7]
34. Dai X, Zhang H, Wu B, Ning W, Chen Y, Chen Y. Correlation between elevated maternal serum alpha-fetoprotein and ischemic placental disease: a retrospective cohort study. Clin Exp Hypertens. 2023;45(1):2175848. [
DOI:10.1080/10641963.2023.2175848] [
PMID]
35. Ozgen G, Adanas Aydin G. The predictive value of maternal serum screening tests for adverse pregnancy outcomes. Ann Med Res. 2021;27(4):1268-74. [
DOI:10.5455/annalsmedres.2020.01.032]